Evidence map›Paper›PMID 26957846›Full record

ArticleMiddle East African journal of ophthalmology

National Burden of Eye Diseases in Iran, 1990-2010; Findings from the Global Burden of Diseases Study 2010.

Elham Hatef, Seyed-Farzad Mohammadi, Cyrus Alinia, Elham Ashrafi, S-Mehrdad Mohammadi, Alireza Lashay, Ali Sadeghi-Tari

Abstract read
In one paragraph

Article in Middle East African journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Economic Burden of Vision Loss and Eye Disorders in Iran.Iranian journal of public health · 2023
    Article
  3. Socioeconomic disparities in the global burden of glaucoma: an analysis of trends from 1990 to 2016.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2020
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Elham HatefGeneral Preventive Medicine Residency Program, Johns Hopkins University, Baltimore, MD, USA.
Seyed-Farzad MohammadiEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran; Center for Non-Communicable Diseases Control, Ministry of Health and Medical Education, Tehran, Iran.
Cyrus AliniaEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Elham AshrafiEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran; Non-Communicable Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Epidemiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
S-Mehrdad MohammadiEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Alireza LashayEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Ali Sadeghi-TariEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Farabi Hospital · IRJohns Hopkins University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe disability-adjusted life-years (DALYs) lost due to eye diseases and trends in DALYs in Iran has not been previously reported. The object of this study is to report the burden of eye diseases in Iran and to compare changes from 1990 to 2010 based on age and gender.

methodsData from the Global Burden of Disease Study 2010 (GBD 2010) are used to report DALYs for cataract, refraction/accommodation (functional) disorders, macular degeneration, and glaucoma.

resultsCataract, refraction/accommodation (functional) disorders, macular degeneration, and glaucoma were the 84(th), 87(th), 138(th), and 151(st) causes of DALY in 1990 and the 89(th), 72(nd), 99(th), and 137(th) in 2010, respectively. Cataract accounted for 0.085% of national DALY in 1990 and 0.09% in 2010, refraction/accommodation (functional) disorders accounted for 0.42% in 1990 and 0.47% in 2010, macular degeneration accounted for 0.017% in 1990 and 0.071% in 2010 and glaucoma accounted for 0.0099% in 1990 and 0.025% in 2010. There was a steady increase in DALY with age for each eye disease for both genders and dichotomized for males and females from 1990 to 2010.

conclusionsEpidemiologic transition is reflected in major ophthalmic and blinding diseases in the GBD data for Iran. The burden of macular degeneration is rising, followed by glaucoma. The burden of presbyopia affected individuals past their middle age. The burden of cataract manifested as a slower increase that could be attributable to better access to treatment.

Indexed as

Quality-Adjusted Life YearsAdultAgedAged, 80 and overEye DiseasesFemaleHealth ExpendituresHumansIranMaleMiddle AgedPersons with DisabilitiesRisk FactorsYoung AdultBlinding Eye DiseasesDisability-Adjusted Life-YearsGlobal Burden of DiseasesIran

Identifiers

PMID26957846
PMCPMC4759911
OpenAlexW2282525284

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.